E-Clinical Solution Software Market worth US$6.8 Billion by 2020, Key Players Dominating Market are PAREXEL International Corporation, BioClinica, OmniComm Systems, Oracle Corporation, and Medidata Solutions

Considering the growing number of leading players expanding their business in India and China, the Asia Pacific e-clinical solution software market is expected to witness tremendous growth in the years to come. By product, the global e-clinical solution software market is classified into clinical trial management, clinical data management, safety solution, randomization, trial supply management, and electronic clinical outcome assessment solutions. Healthcare providers, pharmaceutical companies, and research companies are the major end users of e-clinical solution software.

Some of the leading companies operating in the global e-clinical solution software market are PAREXEL International Corporation, BioClinica, OmniComm Systems, Oracle Corporation, and Medidata Solutions.

Get PDF Sample of the Report - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2548

The report presents a detailed analysis of the software systems designed specifically for managing and analyzing the vast volume of clinical data developed as a result of research activities undertaken by biotechnology, pharmaceutical, medical device companies. Owing to the rapidly increasing availability of highly advanced computer systems and reliable network of the Internet across the globe, the clinical trial industry has become highly connected and sophisticated. The mounting data from the rapidly increasing research activities and integration of computers in the healthcare field have given rise to the increased need for sophisticated e-clinical solution software across the globe.

The report provides a detailed overview of the variety of e-clinical solution software systems in the market. The report examines the key aspects of the market in great details and analyzes the market segments from a global as well as regional standpoint. The report also presents an overview of the impact of regulatory framework, key policies, and regulations on the overall development of the market. The report states that the rising availability of internet and computers has proved to be the biggest boom for the e-clinical solution software market. The effectiveness of these solutions over paper-based data storage and management processes and the continuously rising number of clinical trials focused and an increased spending on clinical research and development activities have also largely propelled the e-clinical solution software market.

The market is expected to expand at an impressive 13.8% between 2014 and 2020, owing to which, the market with a valuation of US$3,005 mn in 2014 will rise to US$6,515.3 mn by 2020. The report categorizes the global e-clinical solution software market on the basis of mode of delivery, product, end-user, and geography.

On the basis of mode of delivery, the market is segmented into web-based, licensed enterprise, and cloud-based e-clinical solution software. On the basis of product, the market is segmented into clinical data management, clinical trial management, electronic clinical outcome assessment, safety solution, and randomization and trial supply management software solutions.

Key end-users of the e-clinical software solution market studied in the report include pharmaceutical, healthcare providers, and chemical research organizations. On the basis of geography, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Of these segments studied in the report, web-based e-clinical software solution ranked as the largest mode of delivery, the pharmaceutical industry ranked as the largest end-use segment, and North America emerged as the largest regional market in 2013.

Read Report with Complete TOC - http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.